Skip to main content

Table 1 Key characteristics and demographic profile of the patients that received MgSO 4

From: Benefits of using magnesium sulphate (MgSO4) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria

Basic characteristics Pre-eclampsia patients (n = 49) Eclampsia patients (n = 996) Total (n = 1045)
  N (%) N (%) N (%)
Age (years)    
  15-19 19(38.8) 519(52.1) 538(51.5)
  20-24 19(38.8) 312(31.3) 331(31.7)
  25-48 10(20.4) 148(14.9) 158(15.1)
  Unknown 1(2.0) 17(1.7) 18(1.7)
Parity    
  0 30(61.2) 601(60.3) 631(60.4)
  1-5 13(26.5) 351(35.2) 364(34.8)
  >5 6(12.2) 33(3.3) 39(3.7)
  Unknown 0 11(1.1) 11(1.1)
Educational status    
  None 36(73.5) 738(74.1) 774(74.1)
  Nursery 3(6.1) 39(3.9) 42(4.0)
  Primary 4(8.2) 138(13.9) 142(13.6)
  Secondary/Vocational 4(8.2) 59(5.9) 63(6.0)
  Tertiary 1(2.0) 4(0.4) 5(0.5)
  Unknown 1(2.0) 18(1.8) 19(1.8)
Marital status    
  Married (monogamous) 37(75.5) 705(70.8) 742(71.0)
  Married (polygamous) 12(24.5) 289(29.0) 301(28.8)
  Unknown 0 2(0.2) 2(0.2)
Blood pressure on admission    
  Normal (SBP ≤ 139/DBP ≤ 89) 0 42 (4.2) 42 (4.2)
  Hypertensive (SBP ≥ 140/DBP ≥ 90) 48 (98.0) 940 (94.4) 988 (94.5)
  Unknown 1 (2.0) 14 (1.4) 15 (1.4)